Advertisement

PKL-Optimality Criterion in Copula Models for Efficacy-Toxicity Response

  • Laura DeldossiEmail author
  • Silvia Angela Osmetti
  • Chiara Tommasi
Conference paper
Part of the Contributions to Statistics book series (CONTRIB.STAT.)

Abstract

In recent years, there has been an increasing interest in developing dose finding methods incorporating both efficacy and toxicity outcomes. It is reasonable to assume that efficacy and toxicity are associated; therefore, we need to model their stochastic dependence. Copula functions are very useful tools to model different kinds of dependence with arbitrary marginal distributions. We consider a binary efficacy-toxicity response with logit marginal distributions. Since the dose which maximizes the probability of efficacy without toxicity (P-optimal dose) changes depending on different copula functions, we propose a criterion which is useful for choosing between the rival copula models but also protects patients against doses that are far away from the P-optimal dose. The performance of this compromise criterion (called PKL) is illustrated for different choices of the parameter values.

Keywords

Marginal Distribution Maximum Tolerate Dose Dependence Structure Dependence Parameter Tail Dependence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Aletti, G., May, C., Tommasi, C.: KL-optimum designs: theoretical properties and practical computation. Stat. Comput. (2014). doi:10.1007/s11222-014-9515-8MathSciNetGoogle Scholar
  2. 2.
    Denman, N.G., McGree, J.M., Eccleston, J.A., Duffull, S.B.: Design of experiments for bivariate binary responses modelled by copula functions. Comput. Stat. Data Anal. 55, 1509–1520 (2011)CrossRefzbMATHMathSciNetGoogle Scholar
  3. 3.
    Dragalin, V., Fedorov, V., Wu, Y.: A two-stage design for dose-finding that accounts for both efficacy and safety. Stat. Med. 27, 5156–5176 (2008)CrossRefMathSciNetGoogle Scholar
  4. 4.
    Fedorov, V., Hackl, P.: Model-Oriented Design of Experiments. Springer, New York (1997)CrossRefzbMATHGoogle Scholar
  5. 5.
    Gao, L., Rosenberger, W.F.: Adaptive Bayesian design with penalty based on toxicity-efficacy response. In: Ucinski, D., Atkinson, A.C., Patan, M. (eds.) mODa 10 – Advances in Model-Oriented Design and Analysis, pp. 91–98. Springer International Publishing, Heidelberg (2013)CrossRefGoogle Scholar
  6. 6.
    López-Fidalgo, L.J., Tommasi, C., Trandafir, P.C.: An optimal experimental design criterion for discriminating between non-normal models. J. R. Stat. Soc. B 69 (2), 231–242 (2007)CrossRefzbMATHMathSciNetGoogle Scholar
  7. 7.
    McGree, J.M., Eccleston, J.A.: Probability-based optimal design. Aust. N. Z. J. Stat. 50, 13–28 (2008)CrossRefMathSciNetGoogle Scholar
  8. 8.
    Nelsen, R.B.: An Introduction to Copulas. Springer, New York (2006)zbMATHGoogle Scholar
  9. 9.
    Perrone, E., Müller, W.G.: Optimal designs for copula models. In: IFAS Research Paper Series 2014–66, Department for Applied Statistics, Johannes Kepler University Linz.http://www.jku.at/ifas/content/e108280/e146255/e241527/ifas_rp66.pdf. Cited May 2014
  10. 10.
    Thall, P.F., Cook, J.D.: Dose-finding based on efficacy-toxicity trade-offs. Biometrics 60, 684–693 (2004)CrossRefzbMATHMathSciNetGoogle Scholar
  11. 11.
    Tommasi, C.: Optimal designs for both model discrimination and parameter estimation. J. Stat. Plan. Inference 139, 4123–4132 (2009)CrossRefzbMATHMathSciNetGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Laura Deldossi
    • 1
    Email author
  • Silvia Angela Osmetti
    • 1
  • Chiara Tommasi
    • 2
  1. 1.Dipartimento di Scienze statisticheUniversità Cattolica del Sacro CuoreMilanItaly
  2. 2.Dipartimento DEMMUniversità degli Studi di MilanoMilanItaly

Personalised recommendations